Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
Clinical data shows palpitations occur in approximately 5-8% of GLP-1 users, often during dose escalation or in individuals with underlying cardiac sensitivity
Blastocyst rate of in vitro embryo production in sheep is affected by season
Peptides can potentially improve symptoms, strengthen the skin barrier, and reduce inflammation, but they do not alter the underlying genetic predisposition
In severe cases, that could potentially cause a life-threatening allergic reaction in the form of anaphylaxis (though this is a theoretical risk, not a proven one)